Article: Linking Nucleoporins, Mitosis, and Colon Cancer

Suppression of a nuclear pore protein Nup358/RanBP2 is linked to mitotic cell death, but the clinical relevance of this link is unknown. In a recent issue of Cell, Vecchione et al. (2016) show that in approximately 10% of BRAF-like colorectal cancer (CC) patients, Nup358/RanBP2 is critical for survival. Treatment with vinorelbine, a microtubule-depolymerizing drug that inhibits mitosis, might be a potential treatment for these CCs.

Citing Articles

Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways.

Zhang X, Lim K, Qiu Y, Hazawa M, Wong R Viruses. 2025; 17(2).

PMID: 40006906 PMC: 11860923. DOI: 10.3390/v17020151.

Nucleoporin Nup58 localizes to centrosomes and mid-bodies during mitosis.

Hartono , Hazawa M, Lim K, Dewi F, Kobayashi A, Wong R Cell Div. 2019; 14:7.

PMID: 31388347 PMC: 6679547. DOI: 10.1186/s13008-019-0050-z.

Colorectal cancer cells require glycogen synthase kinase-3β for sustaining mitosis via translocated promoter region (TPR)-dynein interaction.

Dewi F, Domoto T, Hazawa M, Kobayashi A, Douwaki T, Minamoto T Oncotarget. 2018; 9(17):13337-13352.

PMID: 29568361 PMC: 5862582. DOI: 10.18632/oncotarget.24344.

References

1.

Carethers J, Jung B . Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. Gastroenterology. 2015; 149(5):1177-1190.e3. PMC: 4589489. DOI: 10.1053/j.gastro.2015.06.047. View

2.

Ibarra A, Hetzer M . Nuclear pore proteins and the control of genome functions. Genes Dev. 2015; 29(4):337-49. PMC: 4335290. DOI: 10.1101/gad.256495.114. View

3.

Hashizume C, Kobayashi A, Wong R . Down-modulation of nucleoporin RanBP2/Nup358 impaired chromosomal alignment and induced mitotic catastrophe. Cell Death Dis. 2013; 4:e854. PMC: 3824679. DOI: 10.1038/cddis.2013.370. View

4.

Nofrini V, Di Giacomo D, Mecucci C . Nucleoporin genes in human diseases. Eur J Hum Genet. 2016; 24(10):1388-95. PMC: 5027676. DOI: 10.1038/ejhg.2016.25. View

5.

Dawlaty M, Malureanu L, Jeganathan K, Kao E, Sustmann C, Tahk S . Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell. 2008; 133(1):103-15. PMC: 2693193. DOI: 10.1016/j.cell.2008.01.045. View

6.

Vecchione L, Gambino V, Raaijmakers J, Schlicker A, Fumagalli A, Russo M . A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility. Cell. 2016; 165(2):317-30. DOI: 10.1016/j.cell.2016.02.059. View

7.

Joseph J, Liu S, Jablonski S, Yen T, Dasso M . The RanGAP1-RanBP2 complex is essential for microtubule-kinetochore interactions in vivo. Curr Biol. 2004; 14(7):611-7. DOI: 10.1016/j.cub.2004.03.031. View

8.

Raices M, DAngelo M . Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nat Rev Mol Cell Biol. 2012; 13(11):687-99. DOI: 10.1038/nrm3461. View

9.

Salina D, Enarson P, Rattner J, Burke B . Nup358 integrates nuclear envelope breakdown with kinetochore assembly. J Cell Biol. 2003; 162(6):991-1001. PMC: 2172838. DOI: 10.1083/jcb.200304080. View

10.

Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, Hodgson G . Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J Clin Oncol. 2012; 30(12):1288-95. DOI: 10.1200/JCO.2011.39.5814. View

11.

Mariotto A, Yabroff K, Shao Y, Feuer E, Brown M . Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103(2):117-28. PMC: 3107566. DOI: 10.1093/jnci/djq495. View